glp-1 drugs moa Frontiers GLP-1 and Anesthesia: Considerations and

Global Burden of Diabetes, 1995-2025: Prevalence, Numerical Estimates, and Projections

GLP-1 is accelerating change across portfolios, formats and brand relevance

Ongoing communication is key to personalized care

Those impressive clinical trial outcomes come from prescription medications that go directly into your bloodstream, not herbal supplements sitting on your skin

Adverse effects such as nausea, vomiting, and gastrointestinal discomfort remain common, but usually diminish with time and proper dose escalation

If you need moderate weight loss (10-15% body weight) and cannot tolerate dual-agonist side effects, semaglutide may provide sufficient benefit with better tolerability